LungÕ 2026 – Virtual Global Congress on Lung Oncology
FDA Issues New Guidance on Cell and Gene Therapy Potency
L’OncoDaily Session at London Cancer Week 2026: Advancing the Global Conversation on Cancer Care
Tarlatamab: Mechanism, Neurotoxicity, and the Next Chapter in SCLC Treatment
Financial Discrimination Against Cancer Survivors: Why the Right to Be Forgotten Is a Global Imperative
Ciara Mageean, Olympic Runner and European Champion, Dies at 34 After Stage 4 Bowel Cancer
GDFATHER-NEO: Neoadjuvant Nivolumab + Visugromab in MIBC
Cancer Treatment Side Effects: A MedSafetyWeek 2026 Reminder
OncoDaily Lung is OncoDaily’s dedicated platform for lung cancer, highlighting the latest advances across the rapidly evolving field of thoracic oncology. The platform covers the full spectrum of lung malignancies, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and other thoracic cancers. From clinical trial results and ongoing research to FDA and EMA approvals, updated treatment guidelines, emerging therapies, biomarker discoveries, precision medicine, and major conference data, OncoDaily Lung keeps readers informed about developments shaping the field. The platform also features expert interviews and perspectives from leading specialists in lung and thoracic oncology.
